New York, NY -- (SBWIRE) -- 11/29/2012 -- Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) traded in the range of $4.65 and $5.43 during its latest trading session. The stock had opened at $4.66 and closed at $5.30, up 17.96 percent from its previous close of $4.52. The stock is up on the news of getting positive initial rating from Deutsche Bank. It is currently trading above its 6 days EMA and 20 days EMA prices and thus shows bullish trend. Its MACD also confirms its bullish trend. The stock may go as high as $6.22 level in the coming trading sessions. Idenix’s first support level is at $4.69.
Find out when is the best time to trade IDIX by reading the free trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=IDIX
Galena Biopharma Inc. (NASDAQ:GALE) stock closed its latest trading session at $1.79, up 13.29 percent from its previous close of $1.58. The stock shows bullish trend and it is likely to maintain its upward stance in the short run and medium run. The stock is likely to go up to $1.82 level in the coming trading sessions. Upon breaching this level, the stock may touch $1.87. The stock has received initial rating of Buy from Aegis. Galena is engaged in pharmaceuticals industry and the company was formed in 2003. It is based out of Oregon and it was earlier knowns as RXi Pharmaceuticals Corporation.
Is this the right moment to buy or sell GALE? Find out here: http://www.wallstreetreport.net/market-scan/?symbol=GALE
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
Alexander K. Neumann
WALL STREET REPORT
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)